- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01631890
To Compare the Efficacy of Endoscopic Ultrasound Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed
Phase III Study of the Efficacy of Endoscopic Ultrasound (EUS) Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed
Consecutive patients who meet the eligibility criteria will be enrolled into the study. All patients with gastric varices with no history of gastric variceal bleed (Group C) will undergo Endoscopic ultrasound and Upper Gastrointestinal Endoscopy at baseline, at the end of first year and at the end of study.
The patients who presented to Institute of Liver and Biliary Sciences with gastric variceal bleed or develop Gastric Variceal bleed during hospital stay will be randomized into Group -A (conventional Upper Gastrointestinal Endoscopy + Glue) and Group-B (Endoscopic Ultrasound followed by Upper Gastrointestinal Endoscopy+Glue) therapy for gastric varices. Total 90 patients will be enrolled and randomized into group A and Group B after resuscitation and urgent Upper Gastrointestinal Endoscopy with standard therapy for bleeding gastric varices to achieve hemostasis.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110070
- Institute of liver and Biliary Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A clinical, radiological or histologic diagnosis of cirrhosis
- Upper Gastrointestinal endoscopy showing gastric varices
- Informed consent to participate in the study
Exclusion Criteria:
- Previous endotherapy (Endoscopic Variceal Ligation/Esophageal Variceal Sclerotherapy/Endoscopic Variceal Obliteration) for gastric variceal haemorrhage
- Diagnosed case of HepatoPulmonary Syndrome.
- Non -cirrhotic portal hypertension/Extra hepatic Portal Venous Obstruction
- transhepatic intrajugular portosystemic shunt, (balloon-occluded retrograde transvenous obliteration), balloon-occluded endoscopic injection sclerotherapy, shunt operation.
- Hepatic encephalopathy grade III/IV,
- Cardio respiratory failure
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: standard endotherapy
|
Patients will be stabilized by giving i/v fluids, blood and blood products.
Injection terlipressin will be given to all patients in a bolus dose of 2mg within 30 minutes of admission to the hospital.
This would be followed by 1mg i/v 6hrly and will be continued for 5 days.
If terlipressin cannot given then inj.somatostatin 500mcg IV bolus followed by 250mcg/hr continuous infusion for 5days.
|
Experimental: Endoscopic Ultrasound assisted endoscopic glue injection
|
N Butyl cyanoacrylate will be used for achieving initial hemostasis during active gastric variceal bleed and during follow up gastric variceal obturation.
Endoscopic injection will be performed intravariceally using a therapeutic endoscope and a steel hubbed catheter, with N-butyl-2-cyanoacrylate.
The cyanoacrylate will be injected without dilution with lipiodol.
The tip of the endoscope will be coated with lipiodol to prevent sticking of glue to the endoscope.
The injection catheter is primed with saline solution followed by injection of glue in 1ml aliquot to fill the dead space followed by injection of sterile water to flush the glue into the varix.
The needle is withdrawn immediately after the glue injection to prevent tissue adherence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportions of patients with gastric varices develops rebleed after complete gastric varices obturation in 2 years
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of patients who will achieve complete Gastric variceal obliteration in both groups
Time Frame: 2 years
|
2 years
|
Proportions of patients who will show adverse effects of gastric variceal obturation by N Butyl cyanoacrylate.
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ashok Kr Choudhury, Institute of liver and Biliary Sciences
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ILBS- EUS-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bleeding Gastric Varices
-
Taipei Veterans General Hospital, TaiwanRecruitingLiver Cirrhosis | Bleeding Gastric VaricesTaiwan
-
Institut d'Investigacions Biomèdiques August Pi...Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Hospital Universitario... and other collaboratorsUnknownBleeding Gastric Varices | Portal HypertensionSpain
-
West China HospitalBeijing YouAn Hospital; Guangzhou First People's Hospital; Renmin Hospital of... and other collaboratorsNot yet recruitingPortal Hypertension | Portosystemic Shunt | Gastric Varices Bleeding
-
Kaohsiung Veterans General Hospital.RecruitingLiver Decompensation | Gastric Varices BleedingTaiwan
-
Qilu Hospital of Shandong UniversityEnrolling by invitationLiver Cirrhosis | Bleeding | Gastric Variceal Bleeding | Esophageal Varices BleedingChina
-
Qilu Hospital of Shandong UniversityShandong Provincial Hospital; Taian City Central HospitalRecruitingAnticoagulants and Bleeding Disorders | Tissue Adhesion | Gastric Varices BleedingChina
-
Centre Hospitalier Universitaire VaudoisNot yet recruitingGastric Varix | Gastric Varices Bleeding
-
Unity Health TorontoWithdrawnEndoscopic Ultrasound | Gastric Varices Bleeding
-
Asian Institute of Gastroenterology, IndiaRecruitingGastric Varices BleedingIndia
-
Indiana UniversityCompleted
Clinical Trials on Standard Endotherapy
-
All India Institute of Medical Sciences, New DelhiUnknown
-
Oregon Health and Science UniversityUnited States Department of DefenseActive, not recruitingPancreatic Duct Stricture | Pancreatic Duct Stone | Pancreatic Duct DilatationUnited States
-
University of PennsylvaniaRestaurant AssociatesActive, not recruitingObesity | Weight Gain | Food Preferences | Food SelectionUnited States
-
HealthpointCompleted
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
University of MichiganEnrolling by invitationDepression | Anxiety | Sleep Disturbance | AddictionUnited States
-
Micro Medical Solution, Inc.RecruitingPeripheral Arterial DiseaseUnited States
-
Institute of Cardiology, Warsaw, PolandUnknownCardiac RehabilitationPoland
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted